By Mackenzie Tatananni
From SpaceX to Anthropic, the pipeline of blockbuster initial public offerings is moving fast. But for quantum enthusiasts, the biggest milestone of the year arrives this week as Quantinuum gears up for its trading debut.
The Honeywell-backed upstart is slated to go public on Thursday, according to Nasdaq, meaning the IPO likely will be priced later Wednesday. Shares will be listed on the Nasdaq Global Market under the ticker symbol "QNT."
Just on Monday, the company upsized its IPO to 26.5 million shares for $53 to $55 each. At the top end of the range, Quantinuum would have a market value of $14.3 billion, making it the second-largest publicly traded quantum company behind IonQ.
The IPO caps months of uncertainty for investors looking to Quantinuum as the next big force in quantum computing. Formed in 2021 through a merger between Honeywell Quantum Solutions and a U.K.-based start-up, Quantinuum has built a roster of collaborators across the energy, aerospace, and finance sectors.
It also has secured the backing of the U.S. government. As part of a $2 billion funding package, Quantinuum will receive up to $100 million from the Commerce Department to scale its trapped-ion quantum computers. In turn, the department will receive a minority equity stake in the company.
Last year, Barron's was the first to report that Honeywell was aiming to take the company public sometime between the end of 2026 and 2027, market conditions permitting. The IPO appears to have come to fruition earlier than the company had anticipated in its most conservative timeline.
For quantum bulls, the IPO will be a chance to buy into a company that has been making moves while private, including expanding its geographical footprint and, most importantly, leading in measurable technical benchmarks.
Quantinuum has had ample time to refine its flagship trapped-ion technology, supported by a parent with deep pockets. The company's Helios system has achieved a two-qubit gate fidelity of 99.921% alongside single-qubit fidelity of 99.9975%.
Fidelity is a measure of quality that gauges how closely an actual quantum state or operation matches a target. The system boasts a physical-to-logical qubit ratio of 2:1, signaling a highly efficient error-correction code that bodes well for scaling to larger systems.
Of course, an investment in quantum comes with the usual disclaimers. Ahead of broader commercialization, pure-play quantum companies rely on a concentrated base of early adopters. None of the companies are profitable and all will continue to post losses for the foreseeable future.
By the same token, the IPO presents an attractive entry point for quantum enthusiasts. Investors have a chance to buy into a technical leader that consistently hits or accelerates its deployment targets. Better yet, Quantinuum has the backing of big names like Nvidia and Amgen.
It's just as consequential for Honeywell. The carve-out is part of a broader effort to dismantle its sprawling conglomerate structure and strip away operational distractions. Honeywell is expected to retain a majority stake in Quantinuum as well as voting rights after the IPO.
Write to Mackenzie Tatananni at mackenzie.tatananni@barrons.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 03, 2026 12:28 ET (16:28 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments